Sulfamide as Zinc Binding Motif in Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa)

被引：9

作者：

Halland, Nis ^{[1
]}

Czech, Joerg ^{[1
]}

Czechtizky, Werngard ^{[1
]}

Evers, Andreas ^{[1
]}

Follmann, Markus ^{[1
,2
]}

Kohlmann, Markus ^{[1
]}

Schreuder, Herman A. ^{[1
]}

Kallus, Christopher ^{[1
,3
]}

机构：

[1] Sanofi R&D, Ind Pk Hochst Bldg G838, D-65926 Frankfurt, Germany

[2] Bayer Pharma AG, Aprather Weg 18A, D-42113 Wuppertal, Germany

[3] Bayer Cropsci, Ind Pk Hochst Bldg G836, D-65926 Frankfurt, Germany

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2016年 / 59卷 / 20期

关键词：

PROCARBOXYPEPTIDASE-B; CARBOXYPEPTIDASE-N; ARGININE; PLASMA; TARGET; STATE;

D O I：

10.1021/acs.jmedchem.6b01276

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Previously disclosed TAFIa inhibitors having a urea zinc-binding motif were used as the starting point for the development of a novel class of highly potent inhibitors having a sulfamide zinc-binding motif. High-resolution X-ray cocrystal structures were used to optimize the structures and reveal a highly unusual sulfamide configuration. A selected sulfamide was profiled in vitro and in vivo and displayed a promising ADMET profile.

引用

页码：9567 / 9573

页数：7

共 50 条

[1] Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin
Halland, Nis
Broenstrup, Mark
Czech, Joerg
Czechtizky, Wemgard
Evers, Andreas
Follmann, Markus
Kohlmann, Markus
Schiell, Matthias
Kurz, Michael
Schreuder, Herman A.
Kallus, Christopher
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (11) : 4839 - 4844
[2] Activated thrombin activatable fibrinolysis inhibitor (TAFIA) levels in high pregnancy
Peetz, D.
Dickemann, D.
Interthal, C.
Rolfes, E.
Schinzel, H.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 444 - 444
[3] Phosphinanes and Azaphosphinanes as Potent and Selective Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa)
Schaffner, Arnaud-Pierre
Sansilvestri-Morel, Patricia
Despaux, Nicole
Ruano, Elisabeth
Persigand, Thierry
Rupin, Alain
Mennecier, Philippe
Vallez, Marie-Odile
Raimbaud, Eric
Desos, Patrice
Gloanec, Philippe
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (07) : 3897 - 3910
[4] 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa)
Islam, Imadul
Bryant, Judi
Maya, Karen
Mohan, Raju
Yuan, Shendong
Kent, Lorraine
Morser, John
Zhao, Lei
Vergona, Ron
White, Kathy
Adler, Marc
Whitlow, Marc
Buckman, Brad O.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1349 - 1354
[5] Detecting Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) and Inactivated TAFIa (TAFIai) in Normal and Hemophilia A Plasmas
Hulme, John P.
An, Seong Soo A.
BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2009, 30 (01): : 77 - 82
[6] Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa)
Brink, Mikael
Dahlen, Anders
Olsson, Thomas
Polla, Magnus
Svensson, Tor
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (07) : 2261 - 2268
[7] A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) - Part I: Pharmacological characterization
Wang, Yi-Xin
Zhao, Lei
Nagashima, Mariko
Vincelette, Jon
Sukovich, Drew
Li, Weiwei
Subramanyam, Babu
Yuan, Shendong
Emayan, Kumar
Islam, Imadul
Hrvatin, Paul
Bryant, Judi
Light, David R.
Vergona, Ronald
Morser, John
Buckman, Brad O.
THROMBOSIS AND HAEMOSTASIS, 2007, 97 (01) : 45 - 53
[8] Design and Characterization of a Selenium-Containing Inhibitor of Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa), a Zinc-Containing Metalloprotease
Yoshimoto, Nobuko
Sasaki, Tomoyuki
Sugimoto, Katsuyoshi
Ishii, Hidemi
Yamamoto, Keiko
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (17) : 7696 - 7705
[9] Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases TAFIa level in patients with IBD
Owczarek, Danuta
Undas, Anetta
Foley, Jonathan H.
Nesheim, Michael E.
Jablonski, Konrad
Mach, Tomasz
JOURNAL OF CROHNS & COLITIS, 2012, 6 (01): : 13 - 20
[10] Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets
Ni, Ran
Neves, Miguel A. D.
Wu, Chengliang
Cerroni, Samantha E.
Flick, Matthew J.
Ni, Heyu
Weitz, Jeffrey, I
Gross, Peter L.
Kim, Paul Y.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (09) : 2364 - 2376

← 1 2 3 4 5 →